“Toxicity and Safety of Induction Chemotherapy in Locally Advanced Oropharynx, Hypopharynx and Larynx: Non-Randomized Study Comparing DCF and Immunochemotherapy (ICT) With PF-Pembrolizumab”. 2025. Voprosy Onkologii 70 (6): 1096-1105. https://doi.org/10.37469/0507-3758-2024-70-6-1096-1105.